Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

UNIGENE LABORATORIES INC (UGNE)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05
   10-K10-K10-K10-K/A10-K10-K10-K10-K
CASH FLOWS FROM OPERATING ACTIVITIES:          
    Net Income (Loss)  -34.3-7.1-32.5-13.4    
    Adjustments to reconcile net income (loss) to net cash used in operating activities:          
        Amortization of deferred revenue  -2.9-10.9-1.3     
        Amortization of deferred credit  -0.1-0.1      
        Amortization of debt discounts and deferred financing fees  5.22.91.6     
        Inventory reserves  0.1 0.7     
        Non-cash equity compensation  1.21.31.1     
        Depreciation and amortization of long-lived assets  -2.1-10.2-0.4     
        Loss on investment in Tarsa          
        Changes in operating assets and liabilities:          
            (Increase) decrease in accounts receivable  2.8-1.10.5     
            (Increase) decrease in inventory  1.21.11.9     
            Decrease in other assets  0.5-0.2-0.6     
            Decrease in accounts payable and accrued expenses  7.57.26.10.5    
            Increase in deferred revenue  2.34.84.00.2    
            Increase in accrued interest  8.67.65.6     
            Increase in deferred compensation  0.00.00.00.1    
            Net cash used in operating activities  -3.2-6.8-1.7-11.3    
        CASH FLOWS FROM INVESTING ACTIVITIES:          
            Investment in Tarsa  -0.7-2.8      
            Capital expenditures  -0.2-0.7-0.10.2    
            Increase in patents and other intangibles  -0.1-0.3-0.5     
                Net cash used in investing activities  -1.1-2.7-0.73.0    
   
CASH FLOWS FROM FINANCING ACTIVITIES:          
    Repayment of capital lease  -0.1       
    Proceeds from exercise of stock options  0.00.40.10.3    
        Net cash used in financing activities  3.41.99.74.6    
    Net decrease in cash and cash equivalents  -0.9-7.57.3-3.7    
Cash and cash equivalents at beginning of period  4.712.24.98.6    
Cash and cash equivalents at end of period  3.84.712.24.9    
   
SUPPLEMENTAL CASH FLOW INFORMATION          
Non-cash investing and financing activities:          
    Purchase of equipment through capital lease          
    Cash payments:          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy